Detalhe da pesquisa
1.
Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker.
J Neurooncol
; 161(1): 165-174, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525166
2.
A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer.
Int J Mol Sci
; 24(2)2023 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674914
3.
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection.
Int J Mol Sci
; 23(19)2022 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232363
4.
A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population.
Int J Mol Sci
; 23(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232851
5.
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Cell Mol Neurobiol
; 41(6): 1285-1297, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535722
6.
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Cancer
; 121(3): 372-8, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25236687
7.
Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells.
Cell Oncol (Dordr)
; 45(1): 85-101, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013999
8.
Challenges of diagnostic genomics in Latin America.
Curr Opin Genet Dev
; 66: 101-109, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517184
9.
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.
Mol Ther Nucleic Acids
; 20: 409-420, 2020 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32244168
10.
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.
Transl Oncol
; 13(2): 212-220, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869745
11.
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.
Front Oncol
; 9: 1404, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921661
12.
Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.
PLoS One
; 14(9): e0222709, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31545835
13.
Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
PLoS One
; 13(11): e0206590, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383794
14.
Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility.
Cancers (Basel)
; 10(10)2018 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262796
15.
Breast cancer genetics in young women: What do we know?
Mutat Res Rev Mutat Res
; 774: 33-45, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29173497
16.
Clinical prognostic factors in adults with astrocytoma: Historic cohort.
Clin Neurol Neurosurg
; 146: 116-22, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27208871
17.
Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.
PLoS One
; 10(5): e0126762, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25961742
18.
Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
PLoS One
; 7(5): e37432, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22655046